|
Volumn 60, Issue 10, 2014, Pages 1258-1266
|
What is wrong with clinical proteomics?
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTIBODY;
PEPTIDE;
PROSTATE SPECIFIC ANTIGEN;
PROTEIN;
PROTEOME;
THYROGLOBULIN;
BIOLOGICAL MARKER;
AMINO ACID SEQUENCE;
ANTIBIOTIC SENSITIVITY;
ANTIBIOTIC THERAPY;
ANTIBODY AFFINITY;
ANTICIPATION;
ANTIGEN BINDING;
ATMOSPHERE;
BODY FLUID;
CELLULAR DISTRIBUTION;
CLINICAL LABORATORY;
CLINICAL MEDICINE;
CLINICAL STUDY;
CLINICAL TRIAL (TOPIC);
COMPARATIVE STUDY;
DIAGNOSTIC TEST;
DNA MODIFICATION;
DRUG INDUSTRY;
DRUG MIXTURE;
EARLY DIAGNOSIS;
ECONOMICS;
ENZYME LINKED IMMUNOSORBENT ASSAY;
FALSE NEGATIVE RESULT;
FOOD AND DRUG ADMINISTRATION;
FUNDING;
GENE EXPRESSION;
GENOMICS;
GENOTYPE;
GOLD STANDARD;
HUMAN;
HUMAN GENOME;
IMMUNOASSAY;
IN VITRO STUDY;
LABORATORY DIAGNOSIS;
MANAGED CARE;
MASS SPECTROMETRY;
MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY;
MEDICAID;
MEDICAL RESEARCH;
MEDICARE;
METABOLOME;
MICROBIAL IDENTIFICATION;
MOLECULAR BIOLOGY;
NEXT GENERATION SEQUENCING;
NOTE;
OUTCOME ASSESSMENT;
PATIENT CARE;
PHENOTYPIC VARIATION;
PRIMARY MEDICAL CARE;
PRODUCT DEVELOPMENT;
PROFESSIONAL KNOWLEDGE;
PROGNOSIS;
PROSTATE BIOPSY;
PROSTATE CANCER;
PROTEIN ANALYSIS;
PROTEIN FUNCTION;
PROTEIN PROCESSING;
PROTEIN STRUCTURE;
PROTEIN TARGETING;
PROTEOMICS;
RANDOMIZED CONTROLLED TRIAL (TOPIC);
SENSITIVITY AND SPECIFICITY;
STRUCTURE ANALYSIS;
TISSUES;
VALIDATION STUDY;
MOLECULAR DIAGNOSIS;
PROCEDURES;
TRENDS;
BIOLOGICAL MARKERS;
BIOMEDICAL RESEARCH;
CLINICAL LABORATORY SERVICES;
HUMANS;
MOLECULAR DIAGNOSTIC TECHNIQUES;
PROTEOMICS;
|
EID: 84921765469
PISSN: 00099147
EISSN: 15308561
Source Type: Journal
DOI: 10.1373/clinchem.2014.225185 Document Type: Note |
Times cited : (22)
|
References (0)
|